Literature DB >> 16237376

Influenza vaccination in pregnancy: practices among obstetrician-gynecologists--United States, 2003-04 influenza season.

.   

Abstract

Women infected with influenza virus during pregnancy are at increased risk for serious complications and hospitalization. During 1997-2003, the Advisory Committee on Immunization Practices (ACIP) included healthy pregnant women who would be in their second or third trimester of pregnancy during the influenza season among those persons at high risk for whom influenza vaccination was indicated. Also included were women at any stage of pregnancy with certain chronic medical conditions, such as asthma, diabetes mellitus, or heart disease. ACIP emphasized that the influenza vaccine was safe for breastfeeding mothers and their infants and that household contacts of children aged <2 years also should be vaccinated. However, despite these recommendations, only 13% of pregnant women received influenza vaccination in 2003. To assess understanding of the ACIP recommendations among obstetrician-gynecologists (OB/GYNs), the American College of Obstetricians and Gynecologists (ACOG), with support from CDC, surveyed a national sample of OB/GYNs in May 2004. This report describes the results of that survey, which indicated that 52% of OB/GYNs surveyed would recommend influenza vaccination for a healthy woman in the first trimester of pregnancy, 95% would recommend the vaccine for a healthy pregnant woman beyond the first trimester, and 63% would recommend vaccination for a woman with a medical condition in the first trimester. However, of the physicians who would recommend vaccination, 36%-38% reported that influenza vaccination was not offered in their practices. Increased efforts are needed to improve vaccine availability and to educate OB/GYNs regarding the updated ACIP recommendations on the use of influenza vaccine in the first trimester for both healthy pregnant women and pregnant women at high risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237376

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  H1N1 and influenza viruses: why pregnant women might be hesitant to be vaccinated.

Authors:  Kamelia Mirdamadi; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2011-09       Impact factor: 3.275

2.  Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants.

Authors:  Isaac Benowitz; Daina B Esposito; Kristina D Gracey; Eugene D Shapiro; Marietta Vázquez
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

Review 3.  Protection of children against influenza: Emerging problems.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2017-03-16       Impact factor: 3.452

4.  Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period.

Authors:  Elizabeth Rossmann Beel; Marcia A Rench; Diana P Montesinos; Betsy Mayes; C Mary Healy
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

5.  Attitudes and practices of obstetrician-gynecologists regarding influenza vaccination in pregnancy.

Authors:  Dmitry M Kissin; Michael L Power; Emily B Kahn; Jennifer L Williams; Denise J Jamieson; Kitty MacFarlane; Jay Schulkin; Yujia Zhang; William M Callaghan
Journal:  Obstet Gynecol       Date:  2011-11       Impact factor: 7.623

Review 6.  Risk management of seasonal influenza during pregnancy: current perspectives.

Authors:  Mark H Yudin
Journal:  Int J Womens Health       Date:  2014-07-25

7.  Attitudes of US obstetricians toward a combined tetanus-diphtheria-acellular pertussis vaccine for adults.

Authors:  Sarah J Clark; Soukaina Adolphe; Matthew M Davis; Anne E Cowan; Katrina Kretsinger
Journal:  Infect Dis Obstet Gynecol       Date:  2006

Review 8.  Complications of viral influenza.

Authors:  Michael B Rothberg; Sarah D Haessler; Richard B Brown
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.